Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the …
HM Kantarjian, XG Thomas, A Dmoszynska… - Journal of clinical …, 2012 - ascopubs.org
Purpose This multicenter, randomized, open-label, phase III trial compared the efficacy and
safety of decitabine with treatment choice (TC) in older patients with newly diagnosed acute …
safety of decitabine with treatment choice (TC) in older patients with newly diagnosed acute …
Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the …
HM Kantarjian, XG Thomas, A Dmoszynska… - Journal of Clinical …, 2012 - europepmc.org
Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with
physician advice, of either supportive care or low-dose cytarabine for the treatment of older …
physician advice, of either supportive care or low-dose cytarabine for the treatment of older …
Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the …
HM Kantarjian, XG Thomas… - Journal of …, 2012 - mdanderson.elsevierpure.com
Purpose: This multicenter, randomized, open-label, phase III trial compared the efficacy and
safety of decitabine with treatment choice (TC) in older patients with newly diagnosed acute …
safety of decitabine with treatment choice (TC) in older patients with newly diagnosed acute …
[HTML][HTML] Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose …
HM Kantarjian, XG Thomas… - Journal of Clinical …, 2012 - ncbi.nlm.nih.gov
Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice,
With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment …
With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment …
[PDF][PDF] Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose …
HM Kantarjian, XG Thomas, A Dmoszynska… - J Clin …, 2012 - researchgate.net
Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With
Physician Advice, of Either Suppo Page 1 Multicenter, Randomized, Open-Label, Phase III Trial …
Physician Advice, of Either Suppo Page 1 Multicenter, Randomized, Open-Label, Phase III Trial …
Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine …
HM Kantarjian, XG Thomas, A Dmoszynska… - Journal of Clinical …, 2012 - cir.nii.ac.jp
< jats: sec>< jats: title> Purpose</jats: title>< jats: p> This multicenter, randomized, open-
label, phase III trial compared the efficacy and safety of decitabine with treatment choice …
label, phase III trial compared the efficacy and safety of decitabine with treatment choice …
[引用][C] Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose …
HM KANTARJIAN, XG THOMAS… - Journal of clinical …, 2012 - pascal-francis.inist.fr
Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With
Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older …
Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older …
Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the …
HM Kantarjian, XG Thomas… - Journal of clinical …, 2012 - pubmed.ncbi.nlm.nih.gov
Purpose This multicenter, randomized, open-label, phase III trial compared the efficacy and
safety of decitabine with treatment choice (TC) in older patients with newly diagnosed acute …
safety of decitabine with treatment choice (TC) in older patients with newly diagnosed acute …
Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine …
HM Kantarjian, XG Thomas, A Dmoszynska… - 2012 - muni.cz
This multicenter, randomized, open-label, phase III trial compared the efficacy and safety of
decitabine with treatment choice (TC) in older patients with newly diagnosed acute myeloid …
decitabine with treatment choice (TC) in older patients with newly diagnosed acute myeloid …
[PDF][PDF] Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose …
HM Kantarjian, XG Thomas, A Dmoszynska… - J Clin Oncol, 2012 - academia.edu
Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With
Physician Advice, of Either Suppo Page 1 Multicenter, Randomized, Open-Label, Phase III Trial …
Physician Advice, of Either Suppo Page 1 Multicenter, Randomized, Open-Label, Phase III Trial …